US Stock MarketDetailed Quotes

SMTI Sanara MedTech

Watchlist
  • 32.640
  • +0.220+0.68%
Close Jan 8 16:00 ET
  • 32.110
  • -0.530-1.62%
Pre 04:10 ET
285.31MMarket Cap-32.97P/E (TTM)

Sanara MedTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sanara MedTech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 23.750M--
--2024/Q4-- / 22.750M--
Nov 12, 20242024/Q321.672M / 20.700M--
Aug 12, 20242024/Q220.159M / 19.100M--
May 13, 20242024/Q118.537M / 18.500M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 23.750M--
--2024/Q4-- / 22.750M--
Nov 12, 20242024/Q321.672M / 20.700M--
Aug 12, 20242024/Q220.159M / 19.100M--
May 13, 20242024/Q118.537M / 18.500M--

Unlock Free Earnings Estimates

Sanara MedTech Earnings Reports

  • Sanara MedTech | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 16:09 ET

  • Sanara MedTech | 10-Q: Q2 2024 Earnings Report

    Aug 12, 2024 16:08 ET

  • Sanara MedTech | 10-Q: Q1 2024 Earnings Report

    May 13, 2024 16:15 ET

  • Sanara MedTech | 8-K: Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results

    Mar 25, 2024 16:41 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Collegium Pharmaceutical
    COLL
    +14.41%
    eBay
    EBAY
    +9.86%
    Halozyme Therapeutics
    HALO
    +5.02%
    SilverCrest Metals
    SILV
    +4.63%
    Workday
    WDAY
    +2.01%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 23, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data